Our results suggest that Bcl-2 and c-FLIP/FADD modulators can be employed in a model to study apoptosis induction strategy in iCCA cells and if this approach could be considered for therapeutic strategy in CCA. The gene discussed is CFLAR; the disease is cholangiocarcinoma.